AnaptysBio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AnaptysBio and other ETFs, options, and stocks.About ANAB
AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab.
CEODaniel R. Faga
CEODaniel R. Faga
Employees136
Employees136
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2005
Founded2005
Employees136
Employees136
ANAB Key Statistics
Market cap1.39B
Market cap1.39B
Price-Earnings ratio-17.77
Price-Earnings ratio-17.77
Dividend yield—
Dividend yield—
Average volume416.27K
Average volume416.27K
High today$50.18
High today$50.18
Low today$49.50
Low today$49.50
Open price$49.82
Open price$49.82
Volume187.56K
Volume187.56K
52 Week high$51.43
52 Week high$51.43
52 Week low$12.21
52 Week low$12.21
Stock Snapshot
The current AnaptysBio(ANAB) stock price is $50.10, with a market capitalization of 1.39B. The stock trades at a price-to-earnings (P/E) ratio of -17.77.
On 2025-12-27, AnaptysBio(ANAB) stock moved within a range of $49.50 to $50.18. With shares now at $50.10, the stock is trading +1.2% above its intraday low and -0.1% below the session's peak.
Trading volume for AnaptysBio(ANAB) stock has reached 187.56K, versus its average volume of 416.27K.
Over the past 52 weeks, AnaptysBio(ANAB) stock has traded between a high of $51.43 and a low of $12.21.
Over the past 52 weeks, AnaptysBio(ANAB) stock has traded between a high of $51.43 and a low of $12.21.
Analyst ratings
92%
of 12 ratingsBuy
91.7%
Hold
8.3%
Sell
0%
People also own
Based on the portfolios of people who own ANAB. This list is generated using Robinhood data, and it’s not a recommendation.